diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced the appointment of Pat Arensdorf as general manager and head of the heart failure business unit with responsibility for the development and commercialization of the company’s heart failure biomarkers.
Help employers find you! Check out all the jobs and post your resume.
